Ardelyx Inc (ARDX)
7.90
+0.11
(+1.41%)
USD |
NASDAQ |
May 15, 14:38
Ardelyx Shareholders Equity (Quarterly): 150.89M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 150.89M |
| December 31, 2023 | 166.82M |
| September 30, 2023 | 191.16M |
| June 30, 2023 | 123.16M |
| March 31, 2023 | 125.42M |
| December 31, 2022 | 98.33M |
| September 30, 2022 | 66.86M |
| June 30, 2022 | 53.04M |
| March 31, 2022 | 64.19M |
| December 31, 2021 | 82.62M |
| September 30, 2021 | 81.43M |
| June 30, 2021 | 117.57M |
| March 31, 2021 | 130.81M |
| December 31, 2020 | 126.11M |
| September 30, 2020 | 131.34M |
| June 30, 2020 | 146.35M |
| March 31, 2020 | 167.76M |
| December 31, 2019 | 186.66M |
| September 30, 2019 | 49.16M |
| June 30, 2019 | 68.62M |
| March 31, 2019 | 91.84M |
| Date | Value |
|---|---|
| December 31, 2018 | 115.81M |
| September 30, 2018 | 141.45M |
| June 30, 2018 | 163.41M |
| March 31, 2018 | 128.98M |
| December 31, 2017 | 139.31M |
| September 30, 2017 | 126.64M |
| June 30, 2017 | 144.98M |
| March 31, 2017 | 167.68M |
| December 31, 2016 | 193.15M |
| September 30, 2016 | 222.89M |
| June 30, 2016 | 140.60M |
| March 31, 2016 | 167.75M |
| December 31, 2015 | 108.90M |
| September 30, 2015 | 125.13M |
| June 30, 2015 | 142.26M |
| March 31, 2015 | 58.00M |
| December 31, 2014 | 60.68M |
| September 30, 2014 | 63.30M |
| June 30, 2014 | 62.87M |
| March 31, 2014 | -1.244M |
| December 31, 2013 | -7.324M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
49.16M
Minimum
Sep 2019
191.16M
Maximum
Sep 2023
116.41M
Average
124.29M
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 126.70M |
| Rigel Pharmaceuticals Inc | -31.67M |
| Vistagen Therapeutics Inc | 123.28M |
| Karyopharm Therapeutics Inc | -168.96M |
| Adverum Biotechnologies Inc | 182.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 342.38M |
| Total Liabilities (Quarterly) | 191.49M |
| Debt to Equity Ratio | 0.6616 |
| Current Ratio | 4.534 |
| Net Debt Paydown Yield | -0.86% |